Kevin Patrick Moran - 02 Mar 2026 Form 4 Insider Report for Vanda Pharmaceuticals Inc. (VNDA)

Role: SVP, CFO & Treasurer
Signature: /s/ Kevin Patrick Moran
Issuer symbol: VNDA
Transactions as of: 02 Mar 2026
Net transactions value: -$350,821
Form type: 4
Filing time: 04 Mar 2026, 18:53:14 UTC
Previous filing: 19 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Moran Kevin Patrick	SVP, CFO & Treasurer	2200 PENNSYLVANIA AVENUE NW, SUITE 300E, WASHINGTON	/s/ Kevin Patrick Moran	04 Mar 2026	0001806596

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VNDA	Common Stock	Sale	$350,821	-42,442	-9.4%	$8.27	411,380	02 Mar 2026	Direct	F1, F2
holding	VNDA	Common Stock						635	02 Mar 2026	By Wife

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to the withholding tax provisions of the RSU agreements.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.085 to $8.81, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Content

Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to the withholding tax provisions of the RSU agreements.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.085 to $8.81, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.